BioSante Pharmaceuticals to Present at 2004 UBS Global Life Sciences Conference.LINCOLNSHIRE, Ill. -- BioSante Pharmaceuticals, Inc. (Amex:BPA BPA British Paediatric Association. ) announced today that it is scheduled to present and webcast at the 2004 UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Global Life Sciences Conference in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. on Thursday, September 30, at 3:30 p.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT . Stephen M. Simes, president and chief executive officer of BioSante, will discuss BioSante's hormone therapy Hormone therapy Treating cancers by changing the hormone balance of the body, instead of by using cell-killing drugs. Mentioned in: Breast Cancer, Thyroid Cancer hormone therapy product portfolio including recently reported positive results of a completed Phase II study of LibiGel(TM) (transdermal testosterone gel) for the treatment of female sexual dysfunction. The audio portion of the presentation will be webcast via the Conferences section of the UBS website www.ibb.ubs.com. Please follow the link for the webcast under the Global Life Sciences Conference heading. A replay of the presentation will begin approximately three hours after the presentation and will be available until October 30, 2004. About BioSante Pharmaceuticals, Inc. BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver bioidentical estradiol and testosterone. Symptoms treated with hormone therapy in men include impotence, diminished sex drive, muscle weakness and osteoporosis. Symptoms in menopausal women include hot flashes, vaginal atrophy, decreased libido and osteoporosis. The transdermal gel formulations used in the female gel products are licensed from Antares Pharma, Inc. The estrogen and testosterone markets in the United States alone account for over $2.5 billion in annual sales. The company also is developing its calcium phosphate nanotechnology (CAP) for novel vaccines, including biodefense vaccines for toxins such as anthrax and ricin ricin /ri·cin/ (ri´sin) a phytotoxin in the seeds of the castor oil plant (Ricinus communis), used in the synthesis of immunotoxins. ri·cin n. , and drug delivery systems. Additional information is available online at www.biosantepharma.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion